Shah S, Bal V, Ramesh V, Shao D

Comparative safety analysis of currently approved anti-CD20 monoclonal antibodies for first line treatment of chronic lymphocytic leukemia (CLL). Poster presentation at the International Workshop on Chronic Lymphocytic Leukemi

Leave a reply

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

required